Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Hematology/Oncology and Stem Cell Therapy
|
March 31, 2021
Microbiota phylogenic analysis revealed decreased abundance of Faecalibacterium prausnitzii, an anti-inflammatory commensal bacterium, in patients with chronic graft-versus-host disease
Nosha Farhadfar, Raad Z Gharaibeh, Debra Lyon, et al.
Rheumatology (Oxford, England)
|
March 22, 2018
The subgingival microbiome in patients with established rheumatoid arthritis
Ted R Mikuls, Clay Walker, Fang Qiu, et al.
Scientific Reports
|
December 15, 2021
Stability of healthy subgingival microbiome across space and time
Ryan Tamashiro, Leah Strange, Kristin Schnackenberg, et al.
Cancer Research
|
April 19, 2017
Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
Sarah Tomkovich, Ye Yang, Kathryn Winglee, et al.
Scientific Reports
|
March 7, 2023
Smoking-induced subgingival dysbiosis precedes clinical signs of periodontal disease
Ryan Tamashiro, Leah Strange, Kristin Schnackenberg, et al.
Nucleic Acids Research
|
April 16, 2008
DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer
Gary P Wang, Alexandrine Garrigue, Angela Ciuffi, et al.
Nucleic Acids Research
|
March 19, 2011
A method to sequence and quantify DNA integration for monitoring outcome in gene therapy
Troy Brady, Shoshannah L Roth, Nirav Malani, et al.
BMC Oral Health
|
November 3, 2022
A randomized controlled trial to evaluate the effectiveness of a novel mouth rinse in patients with gingivitis
Bianca A Newman, Claire N Rosebrough, Ryan A Tamashiro, et al.
BMC Oral Health
|
May 9, 2021
Subgingival microbiome of deep and shallow periodontal sites in patients with rheumatoid arthritis: a pilot study
Ryanne Lehenaff, Ryan Tamashiro, Marcelle M Nascimento, et al.
Drugs
|
October 26, 2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Hematology/Oncology and Stem Cell Therapy
|
March 31, 2021
Microbiota phylogenic analysis revealed decreased abundance of Faecalibacterium prausnitzii, an anti-inflammatory commensal bacterium, in patients with chronic graft-versus-host disease
Nosha Farhadfar, Raad Z Gharaibeh, Debra Lyon, et al.
Rheumatology (Oxford, England)
|
March 22, 2018
The subgingival microbiome in patients with established rheumatoid arthritis
Ted R Mikuls, Clay Walker, Fang Qiu, et al.
Scientific Reports
|
December 15, 2021
Stability of healthy subgingival microbiome across space and time
Ryan Tamashiro, Leah Strange, Kristin Schnackenberg, et al.
Cancer Research
|
April 19, 2017
Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis
Sarah Tomkovich, Ye Yang, Kathryn Winglee, et al.
Scientific Reports
|
March 7, 2023
Smoking-induced subgingival dysbiosis precedes clinical signs of periodontal disease
Ryan Tamashiro, Leah Strange, Kristin Schnackenberg, et al.
Nucleic Acids Research
|
April 16, 2008
DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer
Gary P Wang, Alexandrine Garrigue, Angela Ciuffi, et al.
Nucleic Acids Research
|
March 19, 2011
A method to sequence and quantify DNA integration for monitoring outcome in gene therapy
Troy Brady, Shoshannah L Roth, Nirav Malani, et al.
BMC Oral Health
|
November 3, 2022
A randomized controlled trial to evaluate the effectiveness of a novel mouth rinse in patients with gingivitis
Bianca A Newman, Claire N Rosebrough, Ryan A Tamashiro, et al.
BMC Oral Health
|
May 9, 2021
Subgingival microbiome of deep and shallow periodontal sites in patients with rheumatoid arthritis: a pilot study
Ryanne Lehenaff, Ryan Tamashiro, Marcelle M Nascimento, et al.
Drugs
|
October 26, 2022
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection
Sahil Khanna, Maha Assi, Christine Lee, et al.
Page
of 6